Exam 2 Drugs Flashcards
Entecavir (NRTI)
A nucleoside analog with selective and potent activity against Hep B, including Lamivudine-resistant HBV. Most POTENT inhibitor. Slows progression of HBV, and improves liver inflammation and fibrosis that occurs.
SE: diarrhea, headache, fatigue, vomiting, anorexia, chills, upset stomach
Tenofovir PMPA (NtRTI)
Acyclic nucleoside phosphonate Diester analog
-available as an ester prodrug
Inhibits viral reverse transcriptase and acts as a DNA chain terminator
*Inhibits both HIV and HBV Replication
-Acts against Lamivudine-resistant HBV
Adefovir (NtRTI)
A nucleoTide analog used for the tx of HBV infections.
Adefovir diphosphate replaces deoxyadenosine monophosphate in HBV DNA, resulting in DNA chain termination and thus inhibition of DNA replication.
-Slows the progression and improves liver function
-Acts against Lamivudine-resistant HBV
Interferon alfa-2a, Pegylated interferon alfa-2a or alfa-2b
Interferon alfa-2a or 2b acts similarly to endogenous IFN-a
-leads to antiviral, antiproliferative, and immunomodulatory effects
Inhibits viral replication and cleaves ssRNA
AE: flu-like sx, hepatotoxicity, increased risk of infections, and exacerbation of psychiatric conditions
PEGylation: addition of poly(ethylene glycol) increases resistance to proteolytic degradation, increases water solubility, and reduces their antigenicity
True Bacteria
Staph. Aureus
E. Coli
Filamentous Bacteria
Mycobacterium Tuberculosis
M. Leprae
Spirochete
Treponema Pallidum (Syphilis)
Mycoplasma
Mycoplasma Pneumonia
Rickettsia
Rickettsia Prowazekii (Typhus)
Chlamydia
Chlamydia trachomatis (can cause many forms of diseases: sepsis) (blindness)
Colonization
The presence of bacteria that are NOT causing disease
Siderophores
Iron Receptors (bacteria must have iron to multiply)
Can bacterial proliferation rates surpass the protective response?
Yes
Exotoxins
Enzymes released during growth causing specific responses.
Immunogenic (anti-toxin production)
Endotoxins
Lipopolysaccharides contained in the cell walls of Gram (-) organisms.
Pyrogenic Effects
Bacteremia or Septicemia
Presence of bacteria in the blood due to a failure of the body’s defense mechanisms
Usually caused by gram (-) organisms
Bacterial Sepsis
Associated w/ ARDS, DIC, Hemodynamics effects, and renal failure
Gram (+) Bacterial Sepsis
Staphylococcus Aureus
Streptococcus Pneumoniae
S. Aureus is associated w/ an overall mortality rate ranging b/ 10-30%
Gram (-) Bacterial Sepsis
E. Coli
Klebsiella species
Pseudomonas Aeruginosa
-Proeus species, P. Aeruginosa and Acinetobacter species are associated w/ prior antibiotic exposure
Respiratory Infections: Pneumonia
-Community Acquired
Pneumococcal pneumonia (streptococcus pneumonia) Mycoplasma pneumonia in the young
Respiratory Infections: Pneumonia
-Nosocomial Infections (ICU, Ventilators)
Staph. Aureus, Klebsiella pneumonia, P. Aeruginosa
Respiratory Infections: Pneumonia
-Immunocompromised patients
P. Jiroveci
Respiratory Infections: Pneumonia
-Portal Of Entry
Aspiration of oropharyngeal secretions
Inhalation of aerosols
From blood bacteremia
Hepatitis
Inflammation of the liver
Acute Viral Hepatitis
Inflammation of the liver that begins suddenly and lasts a few weeks
Chronic Viral Hepatitis
Inflammation of the liver that lasts at least 6 months
Cirrhosis
Irreversible inflammatory disease of the liver, a leading cause of death
Acute Infection Sequence of Viral Hepatitis
Incubation Period
Prodromal (pre-icteric) Phase: wt loss, fatigue, anorexia, vomiting, and low grade fever
Icteric (Jaundice) Phase: Lasts 2-6 weeks
-hepatomegaly, dark urine, clay colored stools, itching, jaundice as bilirubin builds up in the blood
Recovery Phase: resolution of jaundice
Fulminant HBV
Results from impairment or necrosis of hepatocytes
Hepatitis B Virus
DNA Hepadnaviridae HBsAG - Diagnosis Severe and Chronic Transmission: sexual, Injection-drug use, Perinatal Incubation: 60-180d PX: Hygiene, Vaccine Chronicity: YES Liver Cancer: YES
Hepatitis C Virus
RNA
Flaviviridae Family
Anti-HCV= diagnosis
Mild to severe
Transmission = injection-drug use, Sexual
Incubation: 35-60 days
Hygiene, Blood screen, IFN-a : prophylaxis
Chronicity: YES Liver Cancer: YES
HEP B VIRUS
dsDNA
Chronic HBV carriers- worldwide reservoir of infection
Cirrhosis and Hepatocellular Carcinoma = Complications
Vaccine is based on Australian Antigen
HBV can cause fulminant hepatitis, and irreversible tissue necrosis which requires a liver transplant
Has infected 1/3 of population
360 million chronic carriers
HEP C VIRUS
ssRNA
Complications = Chronic infection, Cirrhosis, and Carcinoma
Hep B/C Complications
Cirrhosis: scarring of the liver marked increase in fibrous connective tissue, resulting in a firm, modular, distorted liver
Decompensated Cirrhosis: increase in portal HTN, Ascites (fluid accumulation in peritoneum), splenomegaly, encephalopathy, Jaundice
Respiratory Infections: TB or Mycobacterium Avium Complex (MAC)
TB has the highest death toll of any infectious pathogen
POE: airborne transmission
TB Detection: Tubercle formation, Caseous necrosis, (+) skin test
Respiratory Infections: Acute Bronchitis
Acute infection or inflammation of the airways or bronchi
Commonly viral pathogen (can become bacterial)
Causes similar sx to pneumonia but does NOT demonstrate pulmonary consolidation and chest infiltrates
Respiratory Infections: Acute Epiglottitis
More common in Children
Severe, rapidly progressive, life-threatening infection of the epiglottis and surrounding area
-usually caused by Haemophilus influenzae type B
Manifestations: high fever, sore throat, inspiratory stridor, and severe respiratory distress
Tx: Emergency airway and antibiotics
UTI
Inflammation of the urinary epithelium following invasion and colonization by some pathogen within the urinary tract
- complicated
- uncomplicated
- persistent
UTI Pathogens
E. Coli
Staphylococcus Saprophyticus
Enterobacter spp
Cystitis
Inflammation of the bladder
Manifestations: frequency, dysuria, urgency, and lower abdominal and/or Supra pubic pain
TX: antimicrobial therapy, increased fluid intake, avoidance of bladder irritants, and urinary analgesics